Cite Filings / OCUL / 0001738048-26-000024
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G/A

Statement of Beneficial Ownership

OCULAR THERAPEUTIX, INC · Filed 2026-02-17 · Acc 0001738048-26-000024

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2026-03-27 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-02-17 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-02-17 4 Chief Operating Officer sold 11,446 shares at $9.04 ($103,472)
  • 2026-02-17 4 Chief Strategy Officer sold 10,348 shares at $9.04 ($93,546)
  • 2026-02-17 4 Dugel Pravin sold 124,882 shares at $9.04 ($1,128,933)
  • 2026-02-17 4 Chief Medical Officer sold 7,863 shares at $9.04 ($71,082)
  • 2026-02-10 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…